Enhanced Production of Sisomicin in Micromonospora inyoensis by Protoplast Mutagenesis and Fermentation Optimization

Jianguo Xu1,2, Shulin Shen3,4, Zhehua Hu1

  • 1Laboratory of Pharmaceutical Engineering, School of Life Science and Health Engineering, Jiangnan University, Wuxi, 214122, China.

Insights

This study enhanced sisomicin (a broad-spectrum aminoglycoside antibiotic) production by developing a high-yielding strain through chemical mutagenesis and optimizing fermentation conditions. The resulting strain achieved a record fermentation titer of 1780 U·mL-1.

Area of Science:

  • Microbiology
  • Biotechnology
  • Fermentation Science

Background:

  • Sisomicin, a key aminoglycoside antibiotic and precursor to netilmicin and plazomicin, suffers from low fermentation yields.
  • Limited production restricts the broader application of sisomicin and its clinically significant derivatives.

Purpose of the Study:

  • To significantly improve sisomicin production through strain breeding and fermentation optimization.
  • To achieve the highest possible fermentation titer for sisomicin.

Main Methods:

  • Chemical mutagenesis of Micromonospora inyoensis OG-1 using diethyl sulfate on protoplasts.
  • Screening for high-yielding, genetically stable mutant strains.
  • Optimization of carbon and nitrogen sources and dissolved oxygen levels in fermentation.

Main Results:

  • A high-yielding mutant strain (H6-32) was developed, increasing sisomicin titer by 42.6% to 1486 U·mL-1.
  • Optimized fermentation conditions, including dissolved oxygen control, yielded a final sisomicin titer of 1780 U·mL-1.
  • Comparative genome analysis identified 13 gene mutations in the high-yielding strain H6-32.

Conclusions:

  • The study successfully developed a high-yielding sisomicin strain and optimized fermentation, achieving a record titer.
  • This work provides a valuable reference for future strain development and fermentation process optimization in antibiotic production.
  • The findings contribute to a deeper understanding of the genetic basis of sisomicin overproduction.

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol01:27

Production of Alcohol

Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...